These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36037757)

  • 1. Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations.
    Kim KH; Kim SH; Park NY; Hyun JW; Kim HJ
    Mult Scler Relat Disord; 2022 Dec; 68():104141. PubMed ID: 36037757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    Feizi P; Sharma K; Pasham SR; Nirwan L; Joseph J; Jaiswal S; Sriwastava S
    J Neuroimmunol; 2022 Oct; 371():577939. PubMed ID: 35939945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on pathology of central nervous system inflammatory demyelinating diseases.
    Kalinowska-Łyszczarz A; Guo Y; Lucchinetti CF
    Neurol Neurochir Pol; 2022; 56(3):201-209. PubMed ID: 35758517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study.
    Lee S; Muccilli A; Schneider R; Selchen D; Krysko KM
    Mult Scler; 2023 Apr; 29(4-5):595-605. PubMed ID: 36840605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    Ismail II; Salama S
    J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
    Rosenthal JF; Hoffman BM; Tyor WR
    J Investig Med; 2020 Feb; 68(2):321-330. PubMed ID: 31582425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine associated demyelination & its association with MOG antibody.
    Netravathi M; Dhamija K; Gupta M; Tamborska A; Nalini A; Holla VV; Nitish LK; Menon D; Pal PK; Seena V; Yadav R; Ravindranadh M; Faheem A; Saini J; Mahadevan A; Solomon T; Singh B
    Mult Scler Relat Disord; 2022 Apr; 60():103739. PubMed ID: 35306244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability.
    Kwon YN; Kim B; Kim JS; Mo H; Choi K; Oh SI; Kim JE; Nam TS; Sohn EH; Heo SH; Kim SB; Park KC; Yoon SS; Oh J; Baek SH; Kim BJ; Park KS; Sung JJ; Jung JH; Kim SJ; Park SH; Waters P; Kim SM
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34711644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.
    Mirmosayyeb O; Ghaffary EM; Vaheb S; Pourkazemi R; Shaygannejad V
    Rev Neurol (Paris); 2023 Apr; 179(4):265-281. PubMed ID: 36658048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
    Manguinao M; Krysko KM; Maddike S; Rutatangwa A; Francisco C; Hart J; Chong J; Graves JS; Waubant E
    Mult Scler Relat Disord; 2019 Oct; 35():50-54. PubMed ID: 31319355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
    Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
    CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.